M R Rafiyan

Suggest Changes
  • Citations Per Year
Learn More
As a multi-targeted anti-angiogenic receptor tyrosine kinase (RTK) inhibitor sunitinib (SUN) has been established for renal cancer and gastrointestinal stromal tumors. In advanced refractory(More)
  • 1